(Q35887421)

10 August 2017

1 reference

title

Safety and tolerability of treatments for allergic rhinitis in children (English)

1 reference

10 August 2017

1 reference

Carlos E Baena-Cagnani

series ordinal

1

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

27

1 reference

10 August 2017

issue

12

1 reference

10 August 2017

page(s)

883-898

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200427120-00005

10 August 2017

exact match

0 references

cites work

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

1 reference

12 December 2020

Effects of inhaled or nasal glucocorticosteroids on adrenal function and growth

1 reference

12 December 2020

Benefit/risk ratio of the antihistamines (H1-receptor antagonists) terfenadine and chlorpheniramine in children

1 reference

12 December 2020

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

1 reference

12 December 2020

Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology

1 reference

12 December 2020

Allergic rhinitis and asthma in children: disease management and outcomes

1 reference

12 December 2020

Systemic effects of intranasal steroids: an endocrinologist's perspective

1 reference

12 December 2020

Alkylamine antihistamine toxicity and review of Pediatric Toxicology Registry of the National Association of Medical Examiners. Report 4: Alkylamines

1 reference

12 December 2020

Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis

1 reference

12 December 2020

Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol

1 reference

12 December 2020

Seasonal allergic rhinitis and antihistamine effects on children's learning.

1 reference

12 December 2020

Medium and long-term growth in children receiving intranasal beclomethasone dipropionate: a clinical experience.

1 reference

12 December 2020

A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis

1 reference

12 December 2020

Loratadine blockade of K(+) channels in human heart: comparison with terfenadine under physiological conditions

1 reference

12 December 2020

Infantile spasms associated with a histamine H1 antagonist

1 reference

12 December 2020

A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis

1 reference

12 December 2020

Proconvulsant effect of ketotifen, a histamine H1 antagonist, confirmed by the use of d-chlorpheniramine with monitoring electroencephalography

1 reference

12 December 2020

Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide

1 reference

12 December 2020

Effect of beclomethasone dipropionate nasal aerosol on serum markers of bone metabolism in children with seasonal allergic rhinitis

1 reference

12 December 2020

Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate

1 reference

12 December 2020

Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray

1 reference

12 December 2020

Allergic rhinitis and its impact on asthma

1 reference

12 December 2020

Learning impairment and allergic rhinitis.

1 reference

12 December 2020

Astemizole-induced cardiac conduction disturbances in a child

1 reference

12 December 2020

Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child

1 reference

12 December 2020

Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis

1 reference

12 December 2020

Knemometric assessment of systemic activity of once daily intranasal dry-powder budesonide in children

1 reference

12 December 2020

Epidemiology of physician-diagnosed allergic rhinitis in childhood.

1 reference

12 December 2020

Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis

1 reference

12 December 2020

Central anticholinergic syndrome from orphenadrine in a 3 year old.

1 reference

12 December 2020

Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity

1 reference

12 December 2020

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

1 reference

12 December 2020

Complications of allergic rhinitis.

1 reference

12 December 2020

A comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of 3- to 6-year-old children with seasonal allergic rhinitis

1 reference

12 December 2020

The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis

1 reference

12 December 2020

Desloratadine activity in concurrent seasonal allergic rhinitis and asthma

1 reference

12 December 2020

Treatment of seasonal allergic rhinitis with once-daily intranasal fluticasone propionate therapy in children. Fluticasone Propionate Collaborative Pediatric Working Group

1 reference

12 December 2020

Efficacy of safety of concurrent use of intranasal flunisolide and oral beclomethasone aerosols in treatment of asthmatics with rhinitis

1 reference

12 December 2020

Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis

1 reference

12 December 2020

Quality of life in adults and children with allergic rhinitis

1 reference

12 December 2020

The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis

1 reference

12 December 2020

Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children.

1 reference

12 December 2020

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

1 reference

12 December 2020

Sedation from H1 antagonists: evaluation methods and experimental results.

1 reference

12 December 2020

Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: what are the options?

1 reference

12 December 2020

Adverse central nervous system effects of older antihistamines in children.

1 reference

12 December 2020

Central nervous system side-effects of antihistamines in schoolchildren

1 reference

12 December 2020

Experience with monoclonal antibodies in allergic mediated disease: seasonal allergic rhinitis

1 reference

12 December 2020

Accidental astemizole overdose in young children

1 reference

12 December 2020

Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects

1 reference

12 December 2020

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study

1 reference

12 December 2020

Cardiovascular safety of fexofenadine HCl

1 reference

12 December 2020

Lysine-vasopressin in the evaluation of the hypothalamic-pituitary-adrenal axis in children with allergic rhinitis treated with intranasal beclomethasone dipropionate or oral prednisone

1 reference

12 December 2020

Cardiotoxic effects of astemizole overdose in children

1 reference

12 December 2020

No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year

1 reference

12 December 2020

Acute ketotifen overdosage. A review of present clinical experience

1 reference

12 December 2020

Nasal powder administration of budesonide for seasonal rhinitis in children and adolescents

1 reference

12 December 2020

Long-term evaluation of the impact of the h1-receptor antagonist cetirizine on the behavioral, cognitive, and psychomotor development of very young children with atopic dermatitis

1 reference

12 December 2020

Accidental childhood death from diphenhydramine overdosage.

1 reference

12 December 2020

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

1 reference

12 December 2020

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

12 December 2020

Safety of fexofenadine in children treated for seasonal allergic rhinitis

1 reference

12 December 2020

Astemizole-induced torsade de pointes

1 reference

12 December 2020

Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole

1 reference

12 December 2020

Paediatric issues relating to the pharmacotherapy of allergic rhinitis

1 reference

12 December 2020

Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids.

1 reference

12 December 2020

Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.

1 reference

12 December 2020

Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child.

1 reference

12 December 2020

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.

1 reference

12 December 2020

Cetirizine for seasonal allergic rhinitis in children aged 2-6 years. A double-blind comparison with placebo

1 reference

12 December 2020

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

1 reference

12 December 2020

An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers

1 reference

12 December 2020

10.2165/00002018-200427120-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1047688060

0 references

1 reference